Literature DB >> 10472422

Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications.

N Stefanis1, S Frangou, J Yakeley, T Sharma, P O'Connell, K Morgan, T Sigmudsson, M Taylor, R Murray.   

Abstract

BACKGROUND: Hippocampal volume reduction has been repeatedly demonstrated in schizophrenia. The relative contribution of genetic and environmental factors to this is unclear.
METHODS: To address this question, we compared volumetric measurements of the left and right hippocampus, obtained using stereological methods from brain MRI scans, from two groups of patients with schizophrenia as well as healthy controls (n = 26). Patients (n = 27) in the first group, had no family history of schizophrenia and had experienced severe pregnancy and birth complications (PBCs). The second group comprised of patients (n = 21) without a history of severe PBCs from families multiply affected with schizophrenia.
RESULTS: Reduction of the left hippocampal volume was associated with the diagnosis of schizophrenia but was present only in patients with a history of severe PBCs; in this group the smaller hippocampal volume, the earlier the onset of psychosis.
CONCLUSIONS: Our findings suggest that environmental factors, in this case severe PBCs, make a significant contribution to hippocampal abnormalities in schizophrenia.

Entities:  

Mesh:

Year:  1999        PMID: 10472422     DOI: 10.1016/s0006-3223(99)00089-x

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  33 in total

1.  Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia.

Authors:  Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni
Journal:  Schizophr Bull       Date:  2010-06-10       Impact factor: 9.306

Review 2.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

3.  Brain growth of the domestic pig (Sus scrofa) from 2 to 24 weeks of age: a longitudinal MRI study.

Authors:  Matthew S Conrad; Ryan N Dilger; Rodney W Johnson
Journal:  Dev Neurosci       Date:  2012-07-06       Impact factor: 2.984

Review 4.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Authors:  Konasale M Prasad; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

Review 5.  [Correlations between risk gene variants for schizophrenia and brain structure anomalies].

Authors:  T Nickl-Jockschat; M Rietschel; T Kircher
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

6.  Influence of obstetric complication severity on brain morphology in schizophrenia: an MR study.

Authors:  G Bersani; A Quartini; G Manuali; A Iannitelli; D Pucci; F Conforti; C Di Biasi; G Gualdi
Journal:  Neuroradiology       Date:  2009-02-13       Impact factor: 2.804

Review 7.  Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Authors:  Christina G S Palmer
Journal:  J Biomed Biotechnol       Date:  2010-04-06

8.  Hippocampal volume deficits and shape deformities in young biological relatives of schizophrenia probands.

Authors:  Beng-Choon Ho; Vincent Magnotta
Journal:  Neuroimage       Date:  2009-11-23       Impact factor: 6.556

9.  MR-determined hippocampal asymmetry in full-term and preterm neonates.

Authors:  Deanne K Thompson; Stephen J Wood; Lex W Doyle; Simon K Warfield; Gary F Egan; Terrie E Inder
Journal:  Hippocampus       Date:  2009-02       Impact factor: 3.899

Review 10.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.